Marshall Wace’s Actinium Pharmaceuticals ATNM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $137K | Buy |
+98,123
| New | +$137K | ﹤0.01% | 2361 |
|
|
2024
Q4 | – | Sell |
-32,934
| Closed | -$61.9K | – | 2375 |
|
|
2024
Q3 | $61.9K | Sell |
32,934
-223,092
| -87% | -$419K | ﹤0.01% | 2225 |
|
|
2024
Q2 | $1.89M | Buy |
256,026
+103,557
| +68% | +$766K | ﹤0.01% | 1271 |
|
|
2024
Q1 | $1.19M | Buy |
+152,469
| New | +$1.19M | ﹤0.01% | 1381 |
|
|
2023
Q2 | – | Sell |
-74,355
| Closed | -$703K | – | 2000 |
|
|
2023
Q1 | $703K | Buy |
74,355
+51,896
| +231% | +$490K | ﹤0.01% | 1532 |
|
|
2022
Q4 | $239K | Buy |
+22,459
| New | +$239K | ﹤0.01% | 2058 |
|
|
2021
Q4 | – | Sell |
-22,469
| Closed | -$199K | – | 3136 |
|
|
2021
Q3 | $199K | Buy |
+22,469
| New | +$199K | ﹤0.01% | 2212 |
|
|
2021
Q2 | – | Sell |
-13,019
| Closed | -$99K | – | 2089 |
|
|
2021
Q1 | $99K | Sell |
13,019
-9,823
| -43% | -$74.7K | ﹤0.01% | 2017 |
|
|
2020
Q4 | $178K | Buy |
+22,842
| New | +$178K | ﹤0.01% | 1616 |
|